InterCure Ltd. (TLV:INCR)

Market Cap	252.23M
Revenue (ttm)	238.85M
Net Income (ttm)	-67.80M
Shares Out	47.16M
EPS (ttm)	-1.48
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	86,304
Average Volume	65,072
Open	548.90
Previous Close	548.90
Day's Range	525.10 - 548.90
52-Week Range	454.10 - 734.20
Beta	0.63
RSI	56.67
Earnings Date	Aug 28, 2025

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 320
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: INCR

Financial Performance

In 2024, InterCure's revenue was 238.85 million, a decrease of -32.82% compared to the previous year's 355.55 million. Losses were -67.80 million, 9.42% more than in 2023.